It is manufactured by Novo Nordisk and is available under two primary brand names: Ozempic FDA-approved for type 2 diabetes management Wegovy FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity Semaglutide is administered as a once-weekly subcutaneous injection, making it one of the most convenient weight loss medications in terms of dosing frequency
Despite these promising results, the authors say they are a long way away from developing a drug for back pain based on this peptide, with one of many obstacles to overcome being formulation
Its a GLP-1 receptor agonist, which means it mimics the effects of a hormone called GLP-1 in the brain (2)
Cirne F, Kappel C, Zhou S, Mukherjee SD, Dehghan M, Petropoulos J-A, et al
The issue of lifestyles was, in fact, highlighted in particular by Weghuber et al